European Indapamide Market Size, Share, Impressive Industry Growth, Analysis Report 2028

 

European indapamide market is estimated to grow significantly at a CAGR of around 3.2% during the forecast period. Europe has a huge economic burden of heart-related diseases such as CVD, CHD, stroke, and other heart diseases. Europe region including UK, Spain, Germany, France, Italy, Sweden, and other EU countries have a huge pool of CVD patients that creates scope for the growth of the indapamide market. The European Stroke Organization (ESO) and Stroke Alliance for Europe (SAFE) published European Stroke Action Plan (ESAP) in May 2018. The aim of the plan is to set a roadmap and goals for the treatment of stroke in Europe by 2030.Indapamide is used as a preventive treatment of stroke in combination with perindopril, therefore, the growing stroke cases in the region further contribute to the growth of the market during the forecast period.

A full report of European Indapamide Market is available at: https://www.omrglobal.com/industry-reports/european-indapamide-market

The European indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-indapamide-market

The companies which are contributing to the growth of the European indapamide market include Merck KGaA, Sanofi S.A., Mylan N.V., Laboratori Baldacci S.p.A., Sandoz International GmbH, Bioindustria L.I.M. S.p.A. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

European Indapamide Market- Segmentation

By Product

·         1.25 MG

·         2.5 MG

By Application

·         High Blood Pressure

·         Heart Failure

·         Others

European Indapamide Market– Segment by Country

·         Germany

·         United Kingdom

·         France

·         Spain

·         Italy

·         Rest of Europe

Company Profiles

·         Bioindustria L.I.M. S.p.A.

·         Grupo Azevedos

·         Krka Group

·         Laboratori Baldacci S.p.A.

·         Merck KGaA

·         Mylan N.V.

·         Sandoz International GmbH

·         Sanofi S.A.

·         Servier Group

·         Teva Pharmaceuticals Industries Ltd.

Reasons to Buying From us –

1.       We cover more than 15 major industries, further segmented into more than 90 sectors.

2.       More than 120 countries are for analysis.

3.       Over 100+ paid data sources mined for investigation.

4.       Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research